Bio Green Med Solution Inc (BGMS)

Bio Green Med Solution Inc is a healthcare company listed on the NASDAQ exchange as common stock under the ticker BGMS. The company is engaged in the distribution, trading, and installation of protective and fire safety materials and equipment, as well as fire protection and prevention systems. In addition, it conducts research and development activities in pharmaceuticals. The business was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia. The company adopted its current name in September 2022, when it was previously known as Cyclacel Pharmaceuticals, Inc.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-BGMS
$1.06
12.7% Upside
Fair
Not available
Not available
Fair
0.0%
November 18, 2026
0.8x
3.1x
6.206 M
2.026 M
0.0%
80.2%
-220.3
-2.8%
11.9%
Valuation • Fair Value

Bio Green Med Solution Inc (NASDAQ-BGMS) Fair Value by Valuation Model

Review the available estimates for Bio Green Med Solution Inc (NASDAQ-BGMS), including Comps Fair Value.

Primary Valuation Read

Fair Value

$1.06

Estimated upside of 12.7% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

Comps Fair Value

$1.06

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 3 available valuation references for Bio Green Med Solution Inc (NASDAQ-BGMS) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Bio Green Med Solution Inc (NASDAQ-BGMS)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

1.861 M

Current operating scale indicator.

Revenue Forecast

100 K

Forward revenue estimate.

EBITDA

-3.623 M

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Bio Green Med Solution Inc (NASDAQ-BGMS) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Bio Green Med Solution Inc (NASDAQ-BGMS)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

6

Mid-range quality score.

Altman Z-Score

-220.3

Lower score that deserves closer risk review.

FCF / Net Income

11.9%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Bio Green Med Solution Inc (NASDAQ-BGMS). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Bio Green Med Solution Inc (NASDAQ-BGMS)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 18, 2026

Days to Earnings

61

Dividend Yield

0.0%

No current dividend yield is indicated.

Payout Ratio

-2.8%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Bio Green Med Solution Inc (NASDAQ-BGMS), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Bio Green Med Solution Inc (NASDAQ-BGMS) Stock Forecast & Technical Outlook

Review Bio Green Med Solution Inc (NASDAQ-BGMS) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Bio Green Med Solution Inc (NASDAQ-BGMS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Bio Green Med Solution Inc (NASDAQ-BGMS) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Buy

The daily technical read for Bio Green Med Solution Inc (NASDAQ-BGMS) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Neutral

The weekly technical read for Bio Green Med Solution Inc (NASDAQ-BGMS) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Bio Green Med Solution Inc (NASDAQ-BGMS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Bio Green Med Solution Inc (NASDAQ-BGMS)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Bio Green Med Solution Inc (NASDAQ-BGMS) has a Hold consensus, with 0 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 0
Hold 1
Sell 0
FAQ Fast Investor Answers

Bio Green Med Solution Inc (NASDAQ-BGMS) Stock FAQ

Data-supported answers about Bio Green Med Solution Inc (NASDAQ-BGMS), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$1.06
Estimated upside 12.7%
Valuation Rating
Undervalued
Estimated upside of 12.7%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Bio Green Med Solution Inc (NASDAQ-BGMS) is $1.06. This implies an estimated upside of 12.7% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 12.7% versus the current market price.

The current financial health read for Bio Green Med Solution Inc (NASDAQ-BGMS) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Bio Green Med Solution Inc (NASDAQ-BGMS) is November 18, 2026.

The latest available data indicates no current dividend yield for Bio Green Med Solution Inc (NASDAQ-BGMS).

The current market capitalization listed for Bio Green Med Solution Inc is 6.206 M.

The current enterprise value listed for Bio Green Med Solution Inc is 2.026 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Bio Green Med Solution Inc is NASDAQ-BGMS, and the stock is listed on NASDAQ.

Bio Green Med Solution Inc (NASDAQ-BGMS) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Bio Green Med Solution Inc is 0.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Bio Green Med Solution Inc is 80.2%. Free float helps investors understand how much of the share base is available for public trading.